Skip NavigationSkip to Content
Return Return to Search Results

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

  1. Author:
    Yeager, M.
    Orr, N.
    Hayes, R. B.
    Jacobs, K. B.
    Kraft, P.
    Wacholder, S.
    Minichiello, M. J.
    Fearnhead, P.
    Yu, K.
    Chatterjee, N.
    Wang, Z. M.
    Welch, R.
    Staats, B. J.
    Calle, E. E.
    Feigelson, H. S.
    Thun, M. J.
    Rodriguez, C.
    Albanes, D.
    Virtamo, J.
    Weinstein, S.
    Schumacher, F. R.
    Giovannucci, E.
    Willett, W. C.
    Cancel-Tassin, G.
    Cussenot, O.
    Valeri, A.
    Andriole, G. L.
    Gelmann, E. P.
    Tucker, M.
    Gerhard, D. S.
    Fraumeni, J. F.
    Hoover, R.
    Hunter, D. J.
    Chanock, S. J.
    Thomas, G.

  2. Author Address

    NCI, Div Canc Epidemiol & Genet, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA. NCI, Pediat Oncol Branch, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA. NCI, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA. Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA. Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA. Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England. Univ Lancaster, Dept Math & Stat, Lancaster LA1 4YF, England. Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA. Natl Inst Publ Hlth, Dept Hlth Promot & Chron Dis Prevent, FIN-00300 Helsinki, Finland. Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA. Hop Tenon, AP HP, CeRePP, F-75970 Paris, France. Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63108 USA. Columbia Univ, Div Hematol & Oncol, New York, NY 10032 USA. NCI, Off Canc Genom, NIH, DHHS, Bethesda, MD 20892 USA.;Chanock, SJ, NCI, Div Canc Epidemiol & Genet, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA.;chanocks@mail.nih.gov
    1. Year: 2007
    2. Date: May
  2. Journal: Nature Genetics
    1. 39
    2. 5
    3. Pages: 645-649
  4. Type of Article: Article
  5. ISSN: 1061-4036
  1. Abstract:

    Recently, common variants on human chromosome 8q24 were found to be associated with prostate cancer risk. While conducting a genome-wide association study in the Cancer Genetic Markers of Susceptibility project with 550,000 SNPs in a nested case-control study ( 1,172 cases and 1,157 controls of European origin), we identified a new association at 8q24 with an independent effect on prostate cancer susceptibility. The most significant signal is 70 kb centromeric to the previously reported SNP, rs1447295, but shows little evidence of linkage disequilibrium with it. A combined analysis with four additional studies ( total: 4,296 cases and 4,299 controls) confirms association with prostate cancer for rs6983267 in the centromeric locus ( P = 9.42 x 10(-13;) heterozygote odds ratio (OR): 1.26, 95% confidence interval ( c. i.): 1.13 - 1.41; homozygote OR: 1.58, 95% c. i.: 1.40 - 1.78). Each SNP remained significant in a joint analysis after adjusting for the other ( rs1447295 P = 1.41 x 10(-11); rs6983267 P = 6.62 x 10(-10)). These observations, combined with compelling evidence for a recombination hotspot between the two markers, indicate the presence of at least two independent loci within 8q24 that contribute to prostate cancer in men of European ancestry. We estimate that the population attributable risk of the new locus, marked by rs6983267, is higher than the locus marked by rs1447295 ( 21% versus 9%).

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1038/ng2022
  3. View record in Web of Science®
  4. WOS: 000245971300020

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel